MEDANTA.NS Profit & Loss
Global Health Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹26.94 Bn | ₹32.75 Bn | ₹36.92 Bn | ₹44.10 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.65 Bn | ₹0.75 Bn | ₹0.79 Bn | ₹0.99 Bn | OtherIncome |
| Total Income | ₹27.59 Bn | ₹33.50 Bn | ₹37.71 Bn | ₹45.09 Bn | Income |
| Cost of Materials Consumed | ₹5.71 Bn | ₹6.88 Bn | ₹7.90 Bn | ₹8.82 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.56 Bn | ₹0.74 Bn | ₹0.92 Bn | ₹1.17 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-0.02 Bn | ₹-0.02 Bn | ₹-0.03 Bn | ₹-0.03 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹6.34 Bn | ₹7.35 Bn | ₹8.25 Bn | ₹10.96 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.78 Bn | ₹0.74 Bn | ₹0.65 Bn | ₹0.79 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹1.50 Bn | ₹1.73 Bn | ₹1.94 Bn | ₹2.23 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹8.22 Bn | ₹9.82 Bn | ₹11.11 Bn | ₹13.98 Bn | OtherExpenses |
| Total Expenses | ₹23.10 Bn | ₹27.23 Bn | ₹30.74 Bn | ₹37.93 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹4.49 Bn | ₹6.27 Bn | ₹6.97 Bn | ₹7.16 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹-0.50 Bn | ₹-0.01 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹4.49 Bn | ₹6.27 Bn | ₹6.47 Bn | ₹7.15 Bn | ProfitBeforeTax |
| Tax Expense | ₹1.23 Bn | ₹1.49 Bn | ₹1.66 Bn | ₹1.61 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹3.26 Bn | ₹4.78 Bn | ₹4.81 Bn | ₹5.54 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | N/A | ₹4.78 Bn | ₹4.81 Bn | ₹5.56 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹12.58 | ₹17.80 | ₹17.92 | ₹20.71 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹12.57 | ₹17.80 | ₹17.92 | ₹20.66 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from MEDANTA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).